Proliferating status of peripheral blood progenitor cells from patients with BCR-ABL positive chronic myelogenous leukemia.

被引：0
|
作者：
Krämer, A [1 ]
Bergmann, J [1 ]
Willer, A [1 ]
Reiter, A [1 ]
Hochhaus, A [1 ]
Hehlmann, R [1 ]
机构：
[1] Univ Heidelberg, Klinikum Mannheim, Med Klin 3, Mannheim, Germany
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2383
引用
收藏
页码：533A / 533A
页数：1
相关论文
共 50 条
  • [21] Targeting BCR-ABL and its downstream signaling cascade as therapy for chronic myelogenous leukemia.
    Donato, NJ
    Wu, J
    Kong, LY
    Meng, F
    Priebe, W
    Talpaz, M
    BLOOD, 2004, 104 (11) : 810A - 810A
  • [22] Dendritic cells from the peripheral blood of patients with chronic myeloid leukemia: Quantification of the myeloid and lymphoid BCR-ABL positive subsets.
    Aswald, J
    Bouman, D
    Sheldon, J
    Jamal, N
    Joulaie, R
    Squire, J
    Messner, HA
    BLOOD, 1999, 94 (10) : 271B - 271B
  • [23] Cytogenetic response to autografting in chronic myelogenous leukemia correlates with the amount of BCR-ABL positive cells in the graft
    Corsetti, MT
    Lerma, E
    Dejana, A
    Cavaliere, M
    Figari, O
    Vassallo, F
    Abate, M
    Luchetti, S
    Piaggio, G
    Parodi, C
    Pira, GL
    Manca, F
    Carella, AM
    EXPERIMENTAL HEMATOLOGY, 2000, 28 (01) : 104 - 111
  • [24] BCR-ABL activity is critical for the immunogenicity of chronic myelogenous leukemia cells.
    Brauer, Katharina M.
    Werth, Daniela
    von Schwarzenberg, Karin
    Bringmann, Anita
    Kanz, Lothar
    Gruenebach, Frank
    Brossart, Peter
    BLOOD, 2006, 108 (11) : 624A - 625A
  • [25] Triphasic exponential decline of BCR-ABL transcripts during imatinib therapy for chronic myelogenous leukemia.
    Miyamura, K
    Ohnishi, K
    Naoe, T
    Takeuchi, H
    Yoshiki, N
    Yagasaki, F
    Fujisawa, S
    Kimura, Y
    Motoji, T
    Imai, K
    Yamane, T
    Yoshida, S
    Miyawaki, S
    Saburi, Y
    Kitamura, K
    Ohno, R
    BLOOD, 2005, 106 (11) : 322A - 322A
  • [26] Quantitative competitive RT-PCR for BCR-ABL on Ph-negative leukaphereses allows the selection of low-contaminated peripheral blood progenitor cells for autografting in chronic myelogenous leukemia.
    Corsetti, MT
    Lerma, E
    Dejana, A
    Celesti, L
    Li Pira, G
    Manca, F
    Carella, AM
    BLOOD, 1998, 92 (10) : 73A - 73A
  • [27] BCR-ABL REARRANGEMENTS IN CHILDREN WITH PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA
    AURER, I
    BUTTURINI, A
    GALE, RP
    BLOOD, 1991, 78 (09) : 2407 - 2410
  • [28] Mosaicism in BCR-ABL protein expression in B cells in chronic myelogenous leukemia
    Weissinger, EM
    Thalmeier, K
    Dull, T
    Grammer, C
    Kempkes, B
    Brielmeier, M
    Schumm, M
    Kolb, HJ
    INTERNATIONAL JOURNAL OF CANCER, 1996, 68 (05) : 577 - 582
  • [29] Targeting BCR-Abl in the treatment of Philadelphia-chromosome positive chronic myelogenous leukemia
    Roskoski, Robert, Jr.
    PHARMACOLOGICAL RESEARCH, 2022, 178
  • [30] Detection of the BCR-ABL fusion gene in natural killer cells in patients with chronic myelogenous leukemia
    Min, CK
    Yang, IH
    Kim, DW
    Lee, JW
    Han, CW
    Min, WS
    Kim, CC
    ACTA HAEMATOLOGICA, 2000, 104 (2-3) : 135 - 138
12345